Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Entia Biosciences Inc. (ERGO) had Weighted-Average Shares Outstanding (Diluted) of 28.14M for the most recently reported fiscal quarter, ending 2016-12-31.
| Income Statement Financials | |
$0.05M |
|
$-0.43M |
|
$0.01M |
|
$0.04M |
|
$0.43M |
|
$-0.39M |
|
$-0.05M |
|
$-0.43M |
|
$-0.43M |
|
$-0.43M |
|
$-0.43M |
|
$-0.43M |
|
$-0.43M |
|
$-0.39M |
|
$-0.31M |
|
28.14M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
28.14M |
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$0.23M |
|
$0.02M |
|
$0.20M |
|
$0.44M |
|
$2.11M |
|
$0.30M |
|
$0.30M |
|
$2.41M |
|
$-1.97M |
|
$-2.15M |
|
$-1.97M |
|
28.15M |
|
| Cash Flow Statement Financials | |
$-0.72M |
|
$-0.01M |
|
$0.77M |
|
$0.02M |
|
$0.08M |
|
$0.05M |
|
$0.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.11 |
|
-- |
|
-- |
|
-0.18 |
|
-0.53 |
|
77.99% |
|
-838.61% |
|
-838.61% |
|
-- |
|
-941.12% |
|
-941.12% |
|
$-0.72M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.15 |
|
5.77 |
|
15.60 |
|
22.00% |
|
20.10% |
|
-98.55% |
|
25.97% |
|
$-0.07 |
|
$-0.03 |
|
$-0.03 |
|